Posted by: 2in10 | 02/10/2012

personalized medicine

Newton Wellesley Hospital’s Family HealthSource Magazine, Winter 2012 issue has a feature aritcle on Personalized Medicine. Tumors are being studied at the molecular level, and treatment for cancer can be tailored to the findings.

Pathology Department staff analyze certain cancer cells to see if they have specific mutations that would mean the patient could be treated with new drugs that target those tumor cells. Lung, breast and colon cancers currently have molecular targeted therapies.

There are drugs to treat recurrent ovarian cancer with certain mutations that are being studied; 30 percent of ovarian cancers have a gene mutation being studied with a targeted therapy. A clinical trial will begin shortly in conjunction with Dana Farber Cancer Institute.

Patients benefit from not being given drugs on a trial and error basis, and care providers and suppliers benefit from being able to direct medical resources to the right patients.




Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s


%d bloggers like this: